A detailed history of Citigroup Inc transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Citigroup Inc holds 110,610 shares of MRVI stock, worth $620,522. This represents 0.0% of its overall portfolio holdings.

Number of Shares
110,610
Previous 58,030 90.61%
Holding current value
$620,522
Previous $415,000 121.45%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$6.84 - $9.73 $359,647 - $511,603
52,580 Added 90.61%
110,610 $919,000
Q2 2024

Aug 12, 2024

SELL
$6.87 - $11.34 $980,953 - $1.62 Million
-142,788 Reduced 71.1%
58,030 $415,000
Q1 2024

May 10, 2024

BUY
$5.11 - $8.76 $649,634 - $1.11 Million
127,130 Added 172.52%
200,818 $1.74 Million
Q4 2023

Feb 09, 2024

SELL
$4.7 - $9.87 $507,026 - $1.06 Million
-107,878 Reduced 59.42%
73,688 $482,000
Q3 2023

Nov 09, 2023

SELL
$9.14 - $12.85 $19.7 Million - $27.7 Million
-2,159,294 Reduced 92.24%
181,566 $1.82 Million
Q2 2023

Aug 10, 2023

SELL
$12.09 - $15.0 $1.02 Million - $1.26 Million
-84,158 Reduced 3.47%
2,340,860 $29.1 Million
Q1 2023

May 11, 2023

BUY
$12.99 - $16.48 $7.51 Million - $9.53 Million
578,343 Added 31.32%
2,425,018 $34 Million
Q4 2022

Feb 09, 2023

SELL
$12.5 - $24.78 $2.38 Million - $4.71 Million
-190,079 Reduced 9.33%
1,846,675 $26.4 Million
Q3 2022

Nov 10, 2022

BUY
$20.6 - $30.37 $10.9 Million - $16.1 Million
531,213 Added 35.28%
2,036,754 $52 Million
Q2 2022

Aug 10, 2022

SELL
$26.05 - $37.48 $512,690 - $737,643
-19,681 Reduced 1.29%
1,505,541 $42.8 Million
Q1 2022

May 12, 2022

BUY
$24.46 - $40.92 $6.06 Million - $10.1 Million
247,667 Added 19.39%
1,525,222 $53.8 Million
Q4 2021

Feb 10, 2022

BUY
$35.0 - $45.94 $13.8 Million - $18.1 Million
393,133 Added 44.45%
1,277,555 $53.5 Million
Q3 2021

Nov 10, 2021

BUY
$36.8 - $60.62 $32.5 Million - $53.6 Million
884,422 New
884,422 $43.4 Million

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $738M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.